Population screening for fracture risk in postmenopausal women - a logical step in reducing the osteoporotic fracture burden?

被引:7
作者
McCloskey, E. V. [1 ,2 ]
Chotiyarnwong, P. [1 ,3 ]
Harvey, N. C. [4 ]
Lorentzon, M. [5 ,6 ]
Kanis, J. A. [2 ,6 ]
机构
[1] Univ Sheffield, Dept Oncol & Metab, MRC Versus Arthrit Ctr Integrated Res Musculoskel, Mellanby Ctr Musculoskeletal Res, Sheffield, S Yorkshire, England
[2] Univ Sheffield, Ctr Metab Bone Dis, Sheffield, S Yorkshire, England
[3] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Orthopaed Surg, Bangkok, Thailand
[4] Univ Southampton, MRC Lifecourse Epidemiol Ctr, Southampton, Hants, England
[5] Univ Gothenburg, Gothenburg, Sweden
[6] Australian Catholic Univ, Melbourne, Vic, Australia
关键词
ESTROGEN PLUS PROGESTIN; BONE-MINERAL DENSITY; COST-EFFECTIVENESS; HIP FRACTURE; OLDER WOMEN; RANDOMIZED-TRIAL; DOUBLE-BLIND; PREVENTION; INTERVENTION; COMMUNITY;
D O I
10.1007/s00198-022-06419-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1631 / 1637
页数:7
相关论文
共 50 条
  • [31] EMAS position statement: The management of postmenopausal women with vertebral osteoporotic fracture
    Triantafyllopoulos, Ioannis K.
    Lambropoulou-Adamidou, Kalliopi
    Nacopoulos, Cleopatra C.
    Papaioannou, Nikolaos A.
    Ceausu, Iuliana
    Depypere, Herman
    Erel, C. Tamer
    Perez-Lopez, Faustino R.
    Schenck-Gustafsson, Karin
    van der Schouw, Yvonne T.
    Simoncini, Tommaso
    Tremollieres, Florence
    Rees, Margaret
    Lambrinoudaki, Irene
    [J]. MATURITAS, 2014, 78 (02) : 131 - 137
  • [32] Parity and risk of hip fracture in postmenopausal women
    M. Kauppi
    M. Heliövaara
    O. Impivaara
    P. Knekt
    A. Jula
    [J]. Osteoporosis International, 2011, 22 : 1765 - 1771
  • [33] LOX gene polymorphisms are associated with osteoporotic vertebral compression fracture in postmenopausal Chinese women
    Xiao, Wenjin
    He, Jinwei
    Fu, Wenzhen
    Xu, Youjia
    Zhang, Zhenlin
    [J]. GENE, 2020, 741
  • [34] Weight change and risk of fracture in postmenopausal women
    Compston, Juliet
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [35] Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
    Masud, Tahir
    McClung, Michael
    Geusens, Piet
    [J]. CLINICAL INTERVENTIONS IN AGING, 2009, 4 : 445 - 449
  • [36] A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture
    O'Hanlon, Claire E.
    Parthan, Anju
    Kruse, Morgan
    Cartier, Shannon
    Stollenwerk, Bjorn
    Jiang, Yawen
    Caloyeras, John P.
    Crittenden, Dania B.
    Barron, Richard
    [J]. CLINICAL THERAPEUTICS, 2017, 39 (07) : 1276 - 1290
  • [37] Effects of hyperprolactinemia on osteoporotic fracture risk in premenopausal women
    Vartej, P
    Poiana, C
    Vartej, I
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2001, 15 (01) : 43 - 47
  • [38] Meta-analysis of hypertension and osteoporotic fracture risk in women and men
    Li, C.
    Zeng, Y.
    Tao, L.
    Liu, S.
    Ni, Z.
    Huang, Q.
    Wang, Q.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (08) : 2309 - 2318
  • [39] Guidelines for fracture risk assessment and management of osteoporosis in postmenopausal women and men above the age of 50 in Qatar
    Alam, Fiaz
    Alsaed, Omar
    Abdulla, Nabeel
    Abdulmomen, Ibrahim
    Lutf, Abdo
    Al Emadi, Samar
    [J]. ARCHIVES OF OSTEOPOROSIS, 2024, 19 (01)
  • [40] Assessment of 10-Year Major Osteoporotic and Femur Fracture Risk of Postmenopausal Women Using FRAX®
    Demir, Ayse
    Kutlu, Ruhusen
    Civi, Selma
    [J]. TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISI-TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION, 2014, 60 : S11 - S18